- 4.4Impact Factor
- 8.8CiteScore
- 21 daysTime to First Decision
Special Issues
Cancers publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Treatment and Prognosis of Pediatric Medulloblastoma
Deadline: 25 November 2026
Current Research in Pediatric Hematological Oncology
Deadline: 31 October 2026
Pediatric Surgery in Oncology: Innovations, Challenges, and Future Directions
Deadline: 30 September 2026
Long-Term Health Outcomes and Quality of Life in Survivors of Childhood Cancer
Deadline: 30 August 2026
Advances in Clinical, Diagnostic and Neurosurgical Management in Pediatric Neuro-Oncology
Deadline: 20 August 2026
Biologic Advancements in Childhood and Adolescent Cancers: From Disease Mechanisms to Precision Therapies
Deadline: 31 July 2026
Advances in Pediatric Liver Cancer Research
Deadline: 20 July 2026
Recent Advances in Hematological Malignancies in Children
Deadline: 30 June 2026
Research Challenges in Adolescent and Young Adult Cancer
Deadline: 30 June 2026
Pediatric Cancers: Advances and Emerging Therapeutic Strategies
Deadline: 30 June 2026
Advances and Challenges in Pediatric Surgical Oncology
Deadline: 10 June 2026
New Advances in the Treatment of Pediatric Solid Tumors
Deadline: 20 May 2026
of 4

